Close Menu

Andrew Yates at Think Gene has a post about direct-to-consumer genomic testing and why programs like the Coriell Institute's Personalized Medicine Collaborative (free to patients) might be taking some of the wind out of corporate sails. "The problem is that DTC genomic companies aren't profitable," Yates writes. With one organization offering to do testing for free, it'll be tougher to convince investors that there's a good chance for return on investment, he says.

 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

NPR says the explosion and fire earlier this week at a Russian lab that stores dangerous pathogens revives the question of whether such samples should be kept.

According to Wired, Nebula Genomics is providing a way for people to get their genomes sequenced anonymously.

A 26-year-old woman tells Cosmopolitan about learning her APOE status at a young age.

In Science journals this week: a functional genomic screen uncovers drug combination that increases KRAS inhibitor efficacy in aggressive lung cancer, and more.